From: Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020)
Gene
Haplotype
1998–2004
(%, n/N)
2005–2010
2011–2016
≥ 2017
P-value
Pfcrt
CVMNK
7.7 (12/156)
20.0 (1/5)
56.1 (101/180)
40.2 (323/804)
P < 0.0001
CVIET
57.1 (89/156)
0.0 (0/5)
36.7 (66/180)
57.9 (301/520)